Vancomycin dosing in obese pediatric patients

Clinical Pediatrics

Volumn 50, Issue 5, 2011, Pages 442-446

  Moffett, Brady S ^a   Kim, Shelly ^a   Edwards, Morven S ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

obesity; overweight; pediatrics; serum concentrations; vancomycin

Indexed keywords

VANCOMYCIN;

ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; MALE; OBESITY; PRESCHOOL CHILD; SCHOOL CHILD;

ANTI-BACTERIAL AGENTS; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; HUMANS; MALE; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79955498224     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922810393500     Document Type: Article

References (13)

1. Pai MP, Bearden DT Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy. 2007 ; 27: 1081-1091.
2. Cheadle WG Risk factors for surgical site infections. Surg Infect (Larchmt). 2006 ; 7 (Suppl 1). S7 - S11.
3. Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009 ; 29: 1275-1279.
4. Frymoyer A., Hersh AL, Benet LZ, Guglielmo BJ Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009 ; 28: 398-402.
5. Frymoyer A., Hersh AL, Coralic Z., Benet LZ, Guglielmo BJ Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther. 2010 ; 32: 534-542.
6. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM Prevalence of high body mass index in U.S. children and adolescents, 2007-2008. JAMA. 2010 ; 303: 242-249.
7. Kendrick JG, Carr RR, Ensom MHH. Pharmacokinetics and drug dosing in obese children. J Pediatr Pharmacol Ther. 2010 ; 15: 94-109.
8. Centers for Disease Control and Prevention. About BMI for children and teens. http://www.cdc.gov/healthyweight/assessing/bmi/childrens-bmi/about- childrens-bmi.html. Accessed July 29, 2009.
9. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am. 1987 ; 34: 571-590. (Pubitemid 17080631)
10. Winter ME Basic Clinical Pharmacokinetics. Vancouver, WA ; Applied Therapeutics ; 1997.
11. Benner KW, Worthington MA, Kimberlin DW, et al. Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. J Pediatr Pharmacol Ther. 2009 ; 14: 86-93.
12. Koshida R., Nakashima E., Taniguchi N., Tsuji A., Benet LZ, Ichimura F. Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological and pharmacokinetic concepts. Pharm Res. 1989 ; 6: 486-491. (Pubitemid 19182185)
13. Jimenez-Truque N., Thomsen I., Saye E., Creech B. Should higher vancomycin trough levels by targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children? Pediatr Infect Dis J. 2010 ; 29: 368-370.